Consolidated Statements of Cash Flows Unaudited (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Statement of Cash Flows [Abstract]
Net loss	$ (71,473,949)	$ (1,182,962)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	9,831	2,843
Amortization of intangible assets	26,637	27,249
Stock options expense	151,701
Common stock issued for services rendered	1,645,000	179,125
Amortization of debt discount	758,348	495,038
Change in fair value of derivative liability	34,507,607	169,753
Expense related to CANX warrant	33,700,000
Loss on extinguishment of debt		2,750
Accrued interest on convertible notes payable	40,983	26,182
Changes in assets and liabilities:
Accounts receivable	(2,022)	10,580
Inventory	(309,838)	20,903
Prepaid expenses	(40,532)	(10,952)
Other receivable	1,169
Deposits	(5,591)
Accounts payable	(28,117)	(76,976)
Accrued expenses	(93,384)	31,390
Deferred revenue	(17,613)	(13,137)
Net cash used in operating activities	(1,129,770)	(318,214)
Cash flows from investing activities
Cash paid for store improvements	(3,925)
Net cash used by investing activities	(3,925)
Cash flows from financing activities
Proceeds from the issuance of common stock		534,760
Proceeds from the issuance of ten percent convertible note		156,000
Proceeds from options exercised	44,673	9,000
Proceeds from notes payable		25,000
Payments on notes payable and accrued interest		(196,508)
Net cash provided by financing activities	44,673	528,252
Net increase in cash equivalents	(1,089,022)	210,038
Cash and cash equivalents, beginning of period	1,831,276	36,602
Cash and cash equivalents, end of period	742,254	246,640
Cash paid for interest		4,865
Cash paid for income taxes
NON-CASH TRANSACTIONS
Common stock issued for services rendered	1,645,000	179,125
Six percent Senior secured convertible notes converted into common stock, principal and interest	32,901	485,275
Seven percent Senior secured convertible notes converted into common stock, principal and interest	618,192
Twelve percent Senior secured convertible notes converted into common stock, principal and interest	439,688
Notes payable for Greners acquisition converted into common stock, principal and interest		156,000
Common stock issued for cashless exercise of options	278	368
Preferred stock cancelled		$ 300